硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 RNF220 抗体对
试剂盒

抗人 RNF220 抗体对

01AB02024

Ring finger protein 220 (RNF220) is an evolutionarily conserved RING-type E3 ubiquitin-protein ligase that is highly expressed in the nervous system. It localizes primarily to the nuclear lamina and regulates signal transduction through both ubiquitin-dependent degradation and protein stabilization. RNF220 targets SIN3B for proteasomal degradation and, independently of its ligase activity, stabilizes β-catenin by recruiting the deubiquitinase USP7, thereby promoting canonical Wnt signaling. It also modulates the Sonic hedgehog (Shh)/Gli and interferon-STAT1 pathways, which are critical for neural patterning and motor neuron development. Clinically, pathogenic variants in RNF220 are associated with hypomyelinating leukodystrophy 23, a disorder characterized by ataxia, deafness, and dilated cardiomyopathy. Its broad influence on developmental signaling pathways also links RNF220 to tumorigenesis and immune dysregulation, reflecting its essential role in cellular homeostasis and neural integrity.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
RNF220
基因别名
C1orf164
蛋白别名
ring finger protein 220; RNF220
UniProt
Q5VTB9
物种
Human

产品详情

靶点名称
RNF220
蛋白名称
ring finger protein 220
蛋白别名
E3 ubiquitin-protein ligase RNF220; RING finger protein 220; RING-type E3 ubiquitin transferase RNF220
靶点基因名
RNF220
基因别名
C1orf164
UniProt
Q5VTB9
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Ring finger protein 220 (RNF220) is an evolutionarily conserved RING-type E3 ubiquitin-protein ligase that is highly expressed in the nervous system. It localizes primarily to the nuclear lamina and regulates signal transduction through both ubiquitin-dependent degradation and protein stabilization. RNF220 targets SIN3B for proteasomal degradation and, independently of its ligase activity, stabilizes β-catenin by recruiting the deubiquitinase USP7, thereby promoting canonical Wnt signaling. It also modulates the Sonic hedgehog (Shh)/Gli and interferon-STAT1 pathways, which are critical for neural patterning and motor neuron development. Clinically, pathogenic variants in RNF220 are associated with hypomyelinating leukodystrophy 23, a disorder characterized by ataxia, deafness, and dilated cardiomyopathy. Its broad influence on developmental signaling pathways also links RNF220 to tumorigenesis and immune dysregulation, reflecting its essential role in cellular homeostasis and neural integrity.